Further validation and investigation into its molecular mechanisms are imperative, especially its interaction with other immune components within the TME, to enhance the understanding of the role of PSMB9 across various cancer types and under different therapeutic conditions to ensure effective, personalized treatment strategies. This evidence concerns the gene PSMB9 and cancer.